MedPath

â??A COMPARATIVE STUDY TO EVALUATE THE EFFICACY OF ABHA GUGGULU AND LAKSHA GUGGULU ALONG WITH DASHMOOLADI MAJJA SNEHA BASTI IN THE MANAGEMENT OF AVASCULAR NECROSIS OF FEMORAL HEAD

Phase 2
Conditions
Health Condition 1: M259- Joint disorder, unspecifiedHealth Condition 2: M871- Osteonecrosis due to drugsHealth Condition 3: M255- Pain in joint
Registration Number
CTRI/2023/04/051675
Lead Sponsor
Pt KHUSHILAL SHARMA GOVT AUTO AYURVEDA COLLEGE INSTITUTE BHOPA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

INCLUSION CRITERIA

I. Patients between the age group of 20-50 year of either sex or religion.

II. Diagnosed cases of Avascular necrosis of femoral head with X-ray or CT of hip joint or MRI of hip joint.

III. Diagnosed case of Avascular necrosis with grade 1 to grade 3.

IV. Patients willing to participate in the trial.

Exclusion Criteria

I. Patients between the age group of 20-50 year of either sex or religion.

II. Diagnosed cases of Avascular necrosis of femoral head with X-ray or CT of hip joint or MRI of hip joint.

III. Diagnosed case of Avascular necrosis with grade 1 to grade 3.

IV. Patients willing to participate in the trial.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1) Group A is more effective than Group B in the management of Asthimajjagata Vata. <br/ ><br>Timepoint: 30 DAYS
Secondary Outcome Measures
NameTimeMethod
It is expected that at the end of study we would be able to demonstrate the efficacy of Abha Guggulu and Laksha Guggulu along with dashmooladi majja sneha basti in the management of Asthimajjagata vataTimepoint: 4 weeks;It is expected that at the end of study we would be able to demonstrate the efficacy of Abha Guggulu and Laksha Guggulu along with dashmooladi majja sneha basti in the management of Asthimajjagata vata (AVN).Timepoint: 30 DAYS
© Copyright 2025. All Rights Reserved by MedPath